Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aurora Cannabis Inc (ACB) vs Okta, Inc. (OKTA) Price & Performance

Aurora Cannabis IncTrade
Okta, Inc.Trade

Price performance (Past 24H)

Key statistics

Aurora Cannabis Inc vs Okta, Inc. — how do they compare? Aurora Cannabis Inc trades at $3.79 (market cap $223.59M), while Okta, Inc. trades at $148.53 (market cap $26.13B). The key difference: Okta, Inc. is far larger — about 116.9× Aurora Cannabis Inc's market cap, and Okta, Inc. is trading nearer its 52-week high, Aurora Cannabis Inc nearer its low. Which is the better fit depends on your goals.

ACBOKTA
Market Cap
$223.59M$26.13B
Sector
HealthTechnology
52-Week High
$6.23$154.62
52-Week Low
$2.58$62.93
Enterprise Value
$168.09M$23.95B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Aurora Cannabis Inc

Aurora Cannabis (ACB) trades at $3.63, up 25.61% amid a hostile takeover bid from Curaleaf at a 45% premium. The stock shows mixed signals with a neutral technical outlook, while fundamentals reveal revenue growth to $343.29M in 2025 but a net income margin of -38.25% and negative ROE. Cash flow improved to a net positive $1.83M in 2025, though 2026 projections indicate renewed losses.

The takeover offer presents a near-term catalyst, but standalone risks persist including profitability challenges and competitive pressures. Analysts are cautious with a majority hold rating. Investors face a binary outcome: accept the premium bid or navigate ACB's volatile fundamentals.

Okta, Inc.

Okta trades at $150.04, down 0.48% today, near its pivot point of $150 with bullish moving averages but overbought RSI signals. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.91 exceeding expectations. Revenue growth is robust, rising to $2.61B in 2025, while the firm achieved GAAP profitability with net income of $28M, a significant turnaround from prior losses. Recent news highlights Okta's acquisition of Permiso Security to enhance AI-driven identity threat detection, positioning it in the expanding cybersecurity market.

Outlook is positive with analyst consensus at Buy (72.55%) and a $129.71 price target, though current price exceeds this. Opportunities include sustained revenue growth and margin expansion, while risks involve high valuation multiples (P/E 108.93) and competitive pressure from Microsoft. Institutional activity shows mixed signals, with some funds increasing stakes amid the stock's 55.6% YTD gain.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Aurora Cannabis Inc

Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.

Read more on ACB

About Okta, Inc.

Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.

Read more on OKTA